髋部骨折后超额死亡:骨折还是骨折前共病?
该研究在新加坡人群中对2008-2017年首次髋部骨折的50岁以上患者按年龄、性别、种族和骨折前Charlson共病指数配对,随访9年。结果显示骨折与共病均独立增加死亡风险,且女性第一年、男性至6年存在显著相加交互作用;骨折后超额死亡归因于骨折和骨折前共病两者。
要点
- 髋部骨折和骨折前共病均独立增加9年死亡风险,调整共病后超额风险仍持续。
- 女性骨折前CCI>4者9年死亡RR为3.29(95%CI 3.01,3.59),无共病者为1.51(95%CI 1.36,1.68)。
- 骨折与高共病存在相加交互:女性第一年RERI 1.99(95%CI 0.97,3.01),男性至6年。
核心结论
- 骨折后超额死亡风险同时归因于骨折本身和骨折前共病,对高共病髋部骨折患者早期干预可能降低超额死亡。
研究设计与样本
- 基于新加坡人群的配对队列研究,纳入2008-2017年首次髋部骨折的50岁以上患者,按年龄、性别、种族和骨折前Charlson共病指数与无髋部骨折队列配对,随访9年。
主要发现
- 髋部骨折和共病在男女中均独立增加9年死亡风险,调整共病后超额死亡风险在骨折后9年仍持续。
- 女性骨折前CCI>4者9年死亡RR为3.29(95%CI 3.01,3.59),无共病者为1.51(95%CI 1.36,1.68),参照组为无骨折无共病者。
- 女性骨折后第一年观察到骨折与骨折前CCI>4的相加交互作用,RERI为1.99(95%CI 0.97,3.01)。
- 男性CCI≥4者阳性相加交互作用观察到6年。
临床怎么用
- 对髋部骨折患者应评估骨折前共病,高共病者可能需早期干预以降低超额死亡。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Comorbidity and hip fracture independently increased mortality risk for 9 years in both sexes, with a significant additive interaction in the first year among women and through 6 years among men. INTRODUCTION: Hip fracture is associated with a persistently elevated mortality risk, but it is unknown whether the elevated risk is due to the fracture or to pre-fracture comorbidity. METHODS: In a population-based study in Singapore with 9 years of follow-up, patients age > 50 with first hip fracture from 2008 to 2017 were pair-matched to a cohort without hip fracture by age, sex, ethnicity, and pre-fracture Charlson Comorbidity Index (CCI). We investigated additive interaction using the relative excess risk due to interaction (RERI) and multiplicative interaction using the ratio of relative risks. RESULTS: Twenty-two thousand five hundred ninety of 22,826 patients with a first hip fracture in 2008-2017 were successfully matched. Hip fracture and comorbidity independently increased mortality risk for 9 years in both sexes. After adjustment for comorbidity, excess mortality risk continued to persist for 9 years post-fracture in both men and women. Women with a hip fracture and pre-fracture CCI > 4 had a higher relative risk (RR) of mortality at 9 years of 3.29 [95% confidence interval (CI) 3.01, 3.59] than those without comorbidity (RR 1.51, 95%CI 1.36, 1.68) compared to the referent without hip fracture or comorbidity. An additive interaction between hip fracture and pre-fracture CCI > 4 was observed in the first post-fracture year` [relative excess risk due to interaction (RERI) 1.99, 95%CI 0.97, 3.01]. For men with CCI ≥ 4, the positive additive interaction was observed through 6 years. CONCLUSIONS: Excess mortality risks post-fracture are attributable to both the fracture and pre-fracture comorbidity. Early interventions in hip fracture patients with high comorbidity could reduce their excess mortality.
引用
- Liow MHL, Ganesan G, Chen JDY, et al. Excess mortality after hip fracture: fracture or pre-fall comorbidity? Osteoporos Int. 2021. PMID: 34129060. doi:10.1007/s00198-021-06023-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。